This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Is Your 401(k) Ignoring These Hot Sectors?

NEW YORK ( TheStreet) -- I cannot emphasize enough how important it is to be invested in the right sectors at the right time. It is just as important to be out of the wrong sectors at the right time.

2012 has been a good year for equity investors so far. The S&P 500 is up about 13% year to date. The tech-heavy Nasdaq is up almost 18%. Sitting on the sidelines of the U.S. stock market has obviously not been a good place to be.

I know all the doom and gloom pundits and newsletter writers have you scared to death. The crash of the dollar is just around the corner and inflation will run wild! While that scenario may play out at some time in the future, sorry Peter Schiff, it has not been a money-making strategy for several years now.

Emerging markets have performed very poorly in 2012. As a group, they are down about 2.2% for the year. Natural resources and commodities have also been a poor place in which to be invested in 2012. The "sell everything and buy gold" mantra may be good for precious metal coin sales, but it has not done much for your 401(k) over the last year.

I have seen many 401(k) plans from a variety of companies over the years. They range from a full palette of Fidelity funds, to a very narrow range of about a dozen funds that cover the various basic asset classes. Some companies, like Qualcomm (QCOM - Get Report) are now allowing participants to invest in individual stocks.

It is hard for me to give advice that fits all 401(k) participants. A lot of it depends upon your age and your tolerance for risk. However, I do have a pretty good handle on the best places to generally be invested in right now. I also have a good feel for the areas to avoid currently.

The medical and biotech sectors, in general, have by far been two of the best places to be invested in this year. With Obamacare looming, many health care related and drug-related companies will benefit from a lot more folks being in the system.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
QCOM $52.13 -1.50%
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs